1. A novel fusion circular RNA F-circBA1 derived from the BCR-ABL fusion gene displayed an oncogenic role in chronic myeloid leukemia cells. Issue 1 (1st January 2021) Authors: Tan, Yuan; Huang, Zhenglan; Wang, Xin; Dai, Hongdan; Jiang, Guoyun; Feng, Wenli Journal: Bioengineered Issue: Volume 12:Issue 1(2021) Page Start: 4816 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A Simple Electrochemical Aptamer Cytosensor for Direct Detection of Chronic Myelogenous Leukemia K562 Cells. Issue 3 (3rd November 2016) Authors: Yu, Tianxiao; Zhang, Hui; Huang, Zhenglan; Luo, Zhenhong; Huang, Ningshu; Ding, Shijia; Feng, Wenli Journal: Electroanalysis Issue: Volume 29:Issue 3(2017) Page Start: 828 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. ABL SH3 mutant inhibits BCR-ABL activity and increases imatinib sensitivity by targeting RIN1 protein in CML cell. Issue 1 (1st December 2015) Authors: Liu, Xin; Li, Yajuan; Wen, Liangxue; Tao, Kun; Xiao, Qing; Cao, Weixi; Huang, Zhenglan; Gao, Miao; Li, Hui; Wang, Fang; Feng, Wenli Journal: Cancer letters Issue: Volume 369:Issue 1(2016) Page Start: 222 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. ABL SH3 mutant inhibits BCR-ABL activity and increases imatinib sensitivity by targeting RIN1 protein in CML cell. Issue 1 (1st December 2015) Authors: Liu, Xin; Li, Yajuan; Wen, Liangxue; Tao, Kun; Xiao, Qing; Cao, Weixi; Huang, Zhenglan; Gao, Miao; Li, Hui; Wang, Fang; Feng, Wenli Journal: Cancer letters Issue: Volume 369:Issue 1(2016) Page Start: 222 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Induction of CML-specific immune response through cross-presentation triggered by CTP-mediated BCR-ABL-derived peptides. (10th July 2020) Authors: Yang, Hao; Zhou, Hongyan; Huang, Zhenglan; Tao, Kun; Huang, Ningshu; Peng, Zhi; Feng, Wenli Journal: Cancer letters Issue: Volume 482(2020) Page Start: 44 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Inhibition of YAP suppresses CML cell proliferation and enhances efficacy of imatinib in vitro and in vivo. Issue 1 (December 2016) Authors: Li, Hui; Huang, Zhenglan; Gao, Miao; Huang, Ningshu; Luo, Zhenhong; Shen, Huawei; Wang, Xin; Wang, Teng; Hu, Jing; Feng, Wenli Journal: Journal of experimental & clinical cancer research Issue: Volume 35:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. LncRNA OIP5-AS1 Promotes the Autophagy-Related Imatinib Resistance in Chronic Myeloid Leukemia Cells by Regulating miR-30e-5p/ATG12 Axis. (October 2021) Authors: Dai, Hongdan; Wang, Jianming; Huang, Zhenglan; Zhang, Hui; Wang, Xin; Li, Qian; Feng, Wenli Journal: Technology in cancer research & treatment Issue: Volume 20(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. MDR1 gene polymorphisms and imatinib response in chronic myeloid leukemia: a meta-analysis. (April 2014) Authors: Zu, Bailing; Li, Yajuan; Wang, Xin; He, Dali; Huang, Zhenglan; Feng, Wenli Journal: Pharmacogenomics Issue: Volume 15:Number 5(2014) Page Start: 667 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗